PHARMACYTE BIOTECH, INC. (PMCB) Net income 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$19.4MFY2026 · since FY2017: -$4.4M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$19.4M | -163.4% |
| FY2025 | $30.7M | +9085.0% |
| FY2024 | $333,763 | +107.7% |
| FY2023 | -$4.3M | -1.8% |
| FY2022 | -$4.2M | -19.4% |
| FY2021 | -$3.6M | +7.2% |
| FY2020 | -$3.8M | +5.9% |
| FY2019 | -$4.1M | +40.4% |
| FY2018 | -$6.8M | -53.7% |
| FY2017 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice